Cargando…
Increased Glutaminolysis Marks Active Scarring in Nonalcoholic Steatohepatitis Progression
BACKGROUND & AIMS: Nonalcoholic steatohepatitis (NASH) occurs in the context of aberrant metabolism. Glutaminolysis is required for metabolic reprograming of hepatic stellate cells (HSCs) and liver fibrogenesis in mice. However, it is unclear how changes in HSC glutamine metabolism contribute to...
Autores principales: | Du, Kuo, Chitneni, Satish K., Suzuki, Ayako, Wang, Ying, Henao, Ricardo, Hyun, Jeongeun, Premont, Richard T., Naggie, Susanna, Moylan, Cynthia A., Bashir, Mustafa R., Abdelmalek, Manal F., Diehl, Anna Mae |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7215180/ https://www.ncbi.nlm.nih.gov/pubmed/31881361 http://dx.doi.org/10.1016/j.jcmgh.2019.12.006 |
Ejemplares similares
-
Serum Bile Acid, Vitamin E, and Serotonin Metabolites Are Associated With Future Liver‐Related Events in Nonalcoholic Fatty Liver Disease
por: Wegermann, Kara, et al.
Publicado: (2021) -
Serum Metabolites Are Associated With HFpEF in Biopsy‐Proven Nonalcoholic Fatty Liver Disease
por: Wegermann, Kara, et al.
Publicado: (2023) -
Serum Interleukin‐8, Osteopontin, and Monocyte Chemoattractant Protein 1 Are Associated With Hepatic Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
por: Glass, Oliver, et al.
Publicado: (2018) -
Branched chain amino acid transaminase 1 (BCAT1) is overexpressed and hypomethylated in patients with non-alcoholic fatty liver disease who experience adverse clinical events: A pilot study
por: Wegermann, Kara, et al.
Publicado: (2018) -
Glycemic Control Predicts Severity of Hepatocyte Ballooning and Hepatic Fibrosis in Nonalcoholic Fatty Liver Disease
por: Alexopoulos, Anastasia‐Stefania, et al.
Publicado: (2021)